The story of how Phibro, a global veterinary pharmaceutical company with over 2,000 products in more than 95 countries, streamlined its end-to-end literature monitoring through a fully outsourced DrugCard service.
The Real-World Struggles of Veterinary Pharmacovigilance
A global veterinary pharmaceutical company faced increasing pressure to manage pharmacovigilance and literature monitoring across eight EU markets. The growing complexity of regulations and manual processes made timely safety surveillance a significant challenge.
Key hurdles included:
- Complex veterinary regulatory requirements across Poland, Lithuania, Latvia, Slovenia, Slovakia, Romania, Bulgaria, and the Czech Republic
- Manual, time-consuming literature screening is slowing down the detection of safety signals
- Limited internal capacity to quickly identify and assess potential adverse events
Without a more efficient system, the risk of missed safety signals increased – potentially affecting both compliance and animal health.
The Solution: Boosting Pharmacovigilance Efficiency with DrugCard
To overcome these challenges, Phibro turned to DrugCard for a fully outsourced, end-to-end literature monitoring solution. Consequently, DrugCard streamlined safety surveillance across all target markets, delivering consistent and timely insights.
Key elements of the solution included:
- Monitoring 45 local journals across the eight EU countries
- Integrated PubMed screening for global literature coverage
- Continuous tracking of 82 products
- Dedicated expert support from DrugCard managing all eight EU markets
By using DrugCard, the company not only achieved a more efficient, reliable, and scalable pharmacovigilance process but also freed internal teams to focus on analysis and decision-making.
The Results: Accurate, Efficient, and Zero Missed Adverse Events
By partnering with DrugCard, the Phibro transformed its pharmacovigilance operations:
- One DrugCard specialist replaced a multi-market team, freeing internal resources for strategic tasks
- Over 3,600 articles screened and categorised in under two months
- High-quality PV standards are maintained with zero compliance gaps, thanks to DrugCard’s automation and expertise
- All findings are tracked and accessible via DrugCard’s intuitive dashboard
- Zero adverse events were missed, and seven safety-relevant entries were flagged and reported promptly
As a result, faster, more efficient literature monitoring across eight EU markets, ensuring complete safety coverage and regulatory compliance.
Ready to Achieve Similar Results?
Instead of letting manual literature screening slow down your pharmacovigilance team, turn to DrugCard. DrugCard automates article monitoring, speeds up safety signal detection, and ensures regulatory compliance across all markets.
Thus, discover how DrugCard can streamline your PV process – book a demo now.
